We Did The Math AVMC Can Go To $77

The Avantis US Mid Cap Equity ETF (AVMC) exhibits an implied analyst target price of $77.11, indicating a 10.49% upside from its recent $69.79 trading price, derived from the weighted average of its underlying holdings' 12-month forward targets. Notable contributors to this projected gain include Hess Midstream LP (HESM) with a 26.70% potential upside, Brown Forman Corp. Class A (BF.A) at 11.65%, and The Gap Inc (GAP) at 11.19%. The analysis, however, underscores the importance for investors to critically assess the justification and recency of these analyst targets.

Analysis

Based on a weighted average of analyst price targets for its underlying holdings, the Avantis US Mid Cap Equity ETF (AVMC) presents a potential 10.49% upside, with an implied target of $77.11 against a recent trading price of $69.79. This projected gain is significantly influenced by key constituents such as Hess Midstream LP (HESM), which exhibits a substantial 26.70% upside to its average analyst target of $44.80. Other notable holdings contributing to the positive outlook include BROWN FORMAN CORP (BF.A) and The Gap Inc (GAP), with implied upsides of 11.65% and 11.19%, respectively. However, the analysis is framed with caution, explicitly questioning whether these analyst targets are justifiably optimistic or simply outdated. This suggests that while the ETF and its specific holdings appear undervalued based on Wall Street consensus, there is a tangible risk that these targets could be revised downwards, necessitating further due diligence from investors to confirm the underlying fundamental strength.

Key Decisions for Investors

• Investors could use the 10.49% implied upside in AVMC as a starting point for evaluating mid-cap exposure, but should verify the concentration and fundamental health of its top holdings.
• For single-stock alpha, Hess Midstream (HESM) warrants deeper research to validate the strong analyst conviction represented by its 26.70% potential upside.
• It is critical to scrutinize the rationale and recency of the analyst targets for key holdings, as the possibility of stale or overly optimistic forecasts constitutes the primary risk to achieving the projected gains.